Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.73 on March 10th

Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend on Monday, December 8th. Stockholders of record on Friday, February 13th will be paid a dividend of 1.73 per share on Tuesday, March 10th. This represents a c) annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, February 13th. This is a 15.3% increase from Eli Lilly and Company’s previous quarterly dividend of $1.50.

Eli Lilly and Company has raised its dividend by an average of 0.2%per year over the last three years and has raised its dividend annually for the last 11 consecutive years. Eli Lilly and Company has a dividend payout ratio of 23.3% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Eli Lilly and Company to earn $31.12 per share next year, which means the company should continue to be able to cover its $6.92 annual dividend with an expected future payout ratio of 22.2%.

Eli Lilly and Company Trading Down 1.9%

Shares of LLY opened at $1,025.06 on Wednesday. The firm has a market cap of $969.08 billion, a price-to-earnings ratio of 44.66, a PEG ratio of 0.90 and a beta of 0.39. The company has a debt-to-equity ratio of 1.71, a quick ratio of 1.24 and a current ratio of 1.55. Eli Lilly and Company has a 52-week low of $623.78 and a 52-week high of $1,133.95. The business’s fifty day moving average is $1,051.59 and its 200-day moving average is $902.97.

Eli Lilly and Company (NYSE:LLY) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $7.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.48 by $0.06. The company had revenue of $19.29 billion for the quarter, compared to analyst estimates of $17.85 billion. Eli Lilly and Company had a net margin of 31.66% and a return on equity of 112.50%. The firm’s revenue was up 42.6% on a year-over-year basis. During the same period in the previous year, the firm posted $5.32 EPS. Eli Lilly and Company has set its FY 2026 guidance at 33.500-35.000 EPS. Equities analysts anticipate that Eli Lilly and Company will post 23.48 EPS for the current fiscal year.

About Eli Lilly and Company

Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.